Dr Peter Penson
Pharmacy and Biomolecular Sciences

Faculty: Faculty of Science
Email address: P.Penson@ljmu.ac.uk
Telephone: 0151 231 2071
Dr Peter Penson is a Senior Lecturer in Pharmacology and Pharmacy Practice at Liverpool John Moores University, UK, Honorary Research Associate at Univerity of Liverpool, UK and an active member of the Liverpool Centre for Cardiovascular Science. In addition, Dr Penson is an Executive Editor of the British Journal of Clinical Pharmacology, Associate Editor of BMC Pharmacology and Toxicology and a Section Editor of Archives of Medical Science: Civilisation Diseases. A Fellow of the Higher Education Academy, he has conducted research at Cardiff University and the University of Surrey, both in the UK, and at the University of Regensburg, Germany. Dr Penson’s research interests include cardiovascular pharmacology and clinical outcomes in cardiovascular disease, with a particular focus on hypertension, dyslipidaemias and ischaemia-reperfusion injury. He is primarily involved in observational studies, clinical trials and meta-analysis. He is a member of the International Lipid Expert Panel and he works with many international experts in the Lipid and Blood Pressure Meta-Analysis Collaboration Group. A pharmacist, registered with the UK General Pharmaceutical Council, Dr Penson is a fellow of The European Society of Cardiology, and a member of The British Cardiovascular Society, The British Pharmacological Society and The British Society for Cardiovascular Research.
Dr Penson teaches cardiovascular physiology, pharmacology and therapeutics on the MPharm. programme. As a pharmacist, he is also involved in teaching Pharmacy Practice elements of the course. He has responsibility for undergraduate and postgraduate masters projects in addition to supervising PhD candidates. Dr Penson leads the third-year of the M.Pharm curriculum, which is organised as a single 120-credit module called 'Complexities of Healthcare'.
Dr Penson is currently an External Examiner for Undergraduate Programmes at UWE Bristol, he has acted as an external examiner for postgraduate Degrees at Coventry University and the University of Birmingham.
He has carried out pedagogic research into the use of lectures and electronic media in teaching and learning in undergraduate pharmacy education. He led a team which conducted a funded research project to identify the learning needs of pharmacists and pharmacy staff in relation to delivery of commissioned services. He is a Fellow of the Higher Education Academy. In 2019 he was designated as a Fellow of the European Society of Cardiology. The fellowship was awarded for scientific excellence.
Degrees
2009, Cardiff University, United Kingdom, Ph.D.
2004, University of Wales, United Kingdom, M.Pharm.
Academic appointments
Honorary Research Associate, University of Liverpool, 2019 - present
Senior Lecturer in Pharmacology and Pharmacy Practice, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 2009 - present
Postgraduate training
Postgraduate Certificate in Learning and Teaching in Higher Education, United Kingdom, Liverpool John Moores University, 2009 - 2010
Highlighted publications
Banach M, Penson PE, Vrablik M, Bunc M, Dyrbus K, Fedacko J, Gaita D, Gierlotka M, Jarai Z, Magda SL, Margetic E, Margoczy R, Durak-Nalbantic A, Ostadal P, Pella D, Trbusic M, Udroiu CA, Vlachopoulos C, Vulic D, Fras Z, Dudek D, Reiner Ž. 2021. OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) Pharmacological Research, :105499-105499 DOI Author Url Publisher Url Public Url
Banach M, Penson P. 2021. Lipid-lowering therapies: Better together Atherosclerosis, DOI Author Url
Banach M, Penson P. 2020. Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go Jama Network Open, DOI Author Url Publisher Url Public Url
Penson P, Pirro M, Banach M. 2020. LDL-C: Lower is Better for Longer - Even at Low Risk BMC Medicine, 18 DOI Author Url Publisher Url Public Url
Penson P. 2020. Spotlight Commentary: What’s new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes British Journal of Clinical Pharmacology, DOI Author Url Public Url
Banach M, Penson P. 2019. Statins and Lp(a): Don’t make perfect the enemy of excellent. European Heart Journal, DOI Author Url
Banach M, Penson P. 2019. Genetic testing in familial hypercholesterolaemia: What does it add? European Journal of Preventative Cardiology, DOI Author Url
Penson P, Long L, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2019. Associations between cardiovascular disease, cancer and very low HDL cholesterol in the REasons for Geographical And Racial Differences in Stroke (REGARDS) study. Cardiovascular Research, 115 :204-212 DOI Author Url Public Url
Penson P, Mancini GBJ, Toth PP, Martin SS, Watts GF, Sahebkar A, Mikhailidis DP, Banach M. 2018. Introducing the 'Drucebo' Effect in Statin Therapy: A systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions. Journal of Cachexia, Sarcopenia and Muscle, DOI Author Url Publisher Url Public Url
Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Martin SS, Mazidi M, Catapano AL, Banach M. 2018. Associations Between Very Low Concentrations of LDL-Cholesterol, hs-CRP and Health Outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study European Heart Journal, 39 :3641-3653 DOI Author Url Public Url
Journal article
Banach M, Katsiki N, Latkovskis G, Rizzo M, Pella D, Penson P, Reiner Z, Cicero A. 2021. Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia Archives of Medical Science, DOI Public Url
Banach M, Penson PE, Vrablik M, Bunc M, Dyrbus K, Fedacko J, Gaita D, Gierlotka M, Jarai Z, Magda SL, Margetic E, Margoczy R, Durak-Nalbantic A, Ostadal P, Pella D, Trbusic M, Udroiu CA, Vlachopoulos C, Vulic D, Fras Z, Dudek D, Reiner Ž. 2021. OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) Pharmacological Research, :105499-105499 DOI Author Url Publisher Url Public Url
Banach M, Penson P. 2021. Lipid-lowering therapies: Better together Atherosclerosis, DOI Author Url
Cybulska B, Kłosiewicz-Latoszek L, Penson PE, Nabavi SM, Lavie CJ, Banach M. 2021. How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors Progress in Cardiovascular Diseases, DOI Author Url Public Url
Zhubi-Bakija F, Bajraktari G, Bytyci I, Mikhailidis DP, Henein MY, Latkovskis G, Rexhaj Z, Zhubi E, Banach M. 2021. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) Clinical Nutrition, 40 :255-276 DOI Author Url Publisher Url Public Url
Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. 2021. Effects of statins on myocarditis: A review of underlying molecular mechanisms Progress in Cardiovascular Diseases, DOI Author Url Public Url
Zaman P, Penson PE, Barreto GE, Sahebkar A. 2020. Recent advancements in liposome-based strategies for effective drug delivery to the brain. Current Medicinal Chemistry, 28 DOI Author Url Publisher Url Public Url
Mazidi M, Mikhailidis DP, Sattar N, Toth PP, Judd S, Blaha MJ, Hernandez AV, Penson P, Banach M. 2020. Association of Types of Dietary Fats and All-Cause and Cause-Specific Mortality: A Prospective Cohort Study and Meta-Analysis of Prospective Studies with 1,148,117 Participants Clinical Nutrition, 39 :3677-3686 DOI Author Url Public Url
Ganjali S, Bianconi V, Penson PE, Pirro M, Banach M, Watts GF, Sahebkar A. 2020. Statins, COVID-19, and coronary artery disease: killing two birds with one stone Metabolism: clinical and experimental, 113 DOI Author Url Publisher Url Public Url
Penson P. 2020. Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes. Atherosclerosis, DOI Author Url Public Url
Banach M, Penson P. 2020. Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go Jama Network Open, DOI Author Url Publisher Url Public Url
Penson P, Pirro M, Banach M. 2020. LDL-C: Lower is Better for Longer - Even at Low Risk BMC Medicine, 18 DOI Author Url Publisher Url Public Url
Penson P, Banach M. 2020. The role of nutraceuticals in the optimization of lipid-lowering therapy in high-risk patients with dyslipidemia. Current Atherosclerosis Reports, DOI Author Url Public Url
Cicero AFG, Fogacci F, Hernandez AV, Banach M. 2020. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis PLoS Medicine, 17 DOI Author Url Publisher Url Public Url
Penson P. 2020. Spotlight Commentary: What’s new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes British Journal of Clinical Pharmacology, DOI Author Url Public Url
Banach M, Penson P, Fras Z, Vrablik M, Pella D, Reiner Z, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M, FH Europe , International Lipid Expert Panel (ILEP) . 2020. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic Pharmacological Research, DOI Author Url Public Url
Gorabi AM, Penson P, Banach M, Motallebnezhad M, Jamialahmadi T, Sahebkar A. 2020. Epigenetic control of atherosclerosis via DNA methylation: a new therapeutic target? Life Sciences, DOI Author Url Public Url
Katsiki N, Mikhailidis DP, Bajraktari G, Miserez AR, Cicero AFG, Bruckert E, Serban M-C, Mirrakhimov E, Alnouri F, Reiner Z, Paragh G, Sahebkar A, Banach M, Amar F, Atanasov AG, Bartlomiejczyk MA, Bjelakovic B, Bielecka-Dabrowa A, Cafferata A, Ceska R, Collet X, Descamps O, Devaki N, Djuric D, Durst R, Ezhov M, Fras Z, Gaita D, von Haehling S, Hernandez A, Jones SR, Jozwiak J, Kakauridze N, Khera A, Kostner K, Kubilius R, Latkovskis G, Mancini GBJ, Marais AD, Martin SS, Martinez JA, Mazidi M, Mitchenko O, Moriarty P, Nabavi SM, Panagiotakos DB, Pella D, Penson PE, Petrulioniene Z, Pirro M, Postadzhiyan A, Puri R, Reda A, Riadh J, Richter D, Rizzo M, Ruscica M, Sattar N, Shehab AMA, Shek AB, Sirtori CR, Stefanutti C, Tomasik T, Toth PP, Viigimaa M, Vinereanu D, Vohnout B, Vrablik M, Wong ND, Yeh H, Jiang Z, Zirlik A. 2020. Statin therapy in athletes and patients performing regular intense exercise-Position paper from the International Lipid Expert Panel (ILEP) PHARMACOLOGICAL RESEARCH, 155 DOI Author Url
Hayat SMG, Jaafari MR, Hatamipour M, Penson PE, Sahebkar A. 2020. Liposome Circulation Time is Prolonged by CD47 Coating. Protein and Peptide Letters: international journal for rapid publication of short papers in protein and peptide science, 27 DOI Author Url Publisher Url Public Url
Jahrami H, Al-Mutarid M, Penson P, Faris M, Saif Z, Hammad L. 2020. Intake of caffeine and its association with physical and mental health status among university students Foods, 9 DOI Author Url Publisher Url Public Url
Cybulska B, Kłosiewicz-Latoszek L, Penson P, Banach M. 2020. What Do We Know About the Role of Lipoprotein(a) in Atherogenesis 57 Years After its Discovery? Progress in Cardiovascular Diseases, DOI Author Url Public Url
Shahbaz SK, Foroughi F, Soltaninezhad E, Jamialahmadi T, Penson P, Sahebkar A. 2020. Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection Expert Opinion on Drug Delivery, DOI Author Url Publisher Url Public Url
Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, Sahebkar A. 2019. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. Journal of clinical medicine, 8 DOI Author Url Publisher Url Public Url
Dyrbuś K, Mariusz G, Penson P, Ray KK, Banach M. 2019. Inclisiran-new hope in the management of lipid disorders? Journal of Clinical Lipidology, DOI Author Url Public Url
Dehnavi S, Sadeghi M, Penson PE, Banach M, Jamialahmadi T, Sahebkar A. 2019. The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis. Journal of clinical medicine, 8 DOI Author Url Publisher Url Public Url
Shahbaz SK, Sadeghi M, Penson P, Koushki K, Sahebkar A. 2019. Regulatory T cells: possible mediators for the anti-inflammatory action of statins Pharmacological Research, DOI Author Url Public Url
Kiaie N, Gorabi AM, Penson PE, Watts G, Johnston TP, Banach M, Sahebkar A. 2019. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome Drug Discovery Today, DOI Author Url Publisher Url Public Url
Chruściel P, Stemplewska P, Stemplewski A, Wattad M, Bielecka-Dąbrowa A, Maciejewski M, Penson P, Bartlomiejczyk M, Banach M. 2019. Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study Archives of Medical Science, 15 DOI Publisher Url Public Url
Gjuladin-Hellon T, Davies IG, Penson P, Amiri Baghbadorani R. 2019. Effects of carbohydrate restricted diets on low density lipoprotein-cholesterol levels in overweight and obese adults: a systematic review and meta-analysis of large randomised controlled trials of at least 6 months Nutrition Reviews, 77 :161-180 DOI Author Url Publisher Url Public Url
Banach M, Penson PE. 2019. What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? Cardiovascular Research, 115 :e26-e31 DOI Author Url Publisher Url Public Url
Bartlomiejczyk MA, Penson P, Banach M. 2019. Worldwide Dyslipidemia Guidelines Current Cardiovascular Risk Reports, 13 DOI Publisher Url Public Url
Penson P, Long L, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2019. Associations between cardiovascular disease, cancer and very low HDL cholesterol in the REasons for Geographical And Racial Differences in Stroke (REGARDS) study. Cardiovascular Research, 115 :204-212 DOI Author Url Public Url
Banach M, Bartlomiejczyk M, Penson P. 2018. Lipoprotein(a) and the risk of atrial fibrillation – is there a link Heart Beat Journal, 2 :49-49 DOI Publisher Url Public Url
Penson P, Mancini GBJ, Toth PP, Martin SS, Watts GF, Sahebkar A, Mikhailidis DP, Banach M. 2018. Introducing the 'Drucebo' Effect in Statin Therapy: A systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions. Journal of Cachexia, Sarcopenia and Muscle, DOI Author Url Publisher Url Public Url
Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Martin SS, Mazidi M, Catapano AL, Banach M. 2018. Associations Between Very Low Concentrations of LDL-Cholesterol, hs-CRP and Health Outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study European Heart Journal, 39 :3641-3653 DOI Author Url Public Url
Franczyk B, Gluba-Brzozka A, Jurkiewicz L, Penson P, Banach M, Rysz J. 2018. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? Expert Opinion on Pharmacotherapy, DOI Author Url Publisher Url Public Url
Sosnowska B, Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. 2017. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis ATHEROSCLEROSIS, 265 :275-282 DOI Author Url Public Url
Maierean S, Serban MC, Sahebkar A, Ursoniu S, Serban A, Penson P, Banach M. 2017. The Effects of Cinnamon Supplementation on Plasma Lipid Concentrations: A Systematic Review and Meta-Analysis Journal of Clinical Lipidology, DOI Author Url Public Url
Ursoniu S, Mikhailidis D, Serban M, Penson P, Toth P, Ridker P, Ray K, Hovingh G, Kastelein J, Hernandez A, Manson J, Rysz J, Banach M. 2017. The Effect Of Statins On Cardiovascular Outcomes By Smoking Status: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials. Pharmacological Research, 122 :105-117 DOI Author Url Public Url
Awad K, Sahebkar A, Penson P, Mikhailidis D, Toth P, Jones S, Rizzo M, Howard G, Lip G, Banach M. 2017. Effects of Morning Versus Evening Statin Administration on Lipid Profile: A Systematic Review And Meta-Analysis Journal of Clinical Lipidology, DOI Author Url Public Url
Sahebkar A, Serban M-C, Penson P, Gurban C, Ursoniu S, Toth P, Jones S, Lippi G, Kotani K, Kostner K, Rizzo M, Rysz J, Banach M. 2017. The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Drugs, DOI Author Url Public Url
Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. 2017. Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease JOURNAL OF CLINICAL LIPIDOLOGY, 11 :617-623 DOI Author Url
Sosnowska B, Penson P, Banach M. 2017. THE ROLE OF NUTRACEUTICALS IN THE PREVENTION OF CARDIOVASCULAR DISEASE Cardiovascular Diagnosis and Therapy, DOI Author Url Public Url
Mazidi M, Penson P, Banach M. 2017. Association between telomere length and complete blood count in US adults. Archives of medical science : AMS, 13 :601-605 DOI Author Url Publisher Url Public Url
Penson P, Serban M-C, Ursoniu S, Banach M. 2017. Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review Critical Reviews in Food Science and Nutrition, DOI Author Url Public Url
Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, 27 :251-259 DOI Author Url Public Url
Awad K, Penson P, Banach M. 2016. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent Pharmacological Research, 114 :42-46 DOI Author Url Public Url
Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, DOI Author Url Public Url
Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, DOI Author Url Public Url
Brie D, Penson P, Serban M-C, Toth P, Serruys P, Banach M. 2016. Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, DOI Author Url Public Url
Dinca M, Serban M-C, Sahebkar A, Mikhailidis D, Toth P, Martin S, Blaha M, Blueher M, Gurban C, Penson P, Michos E, Hernandez A, Jones S. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, DOI Author Url Public Url
Penson PE. 2012. Lecturing: A lost art Currents in Pharmacy Teaching and Learning, 4 :72-76 DOI
Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M-3) RECEPTORS COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 76 :781-801 DOI Author Url
Penson PE, Ford WR, Kidd EJ, Broadley KJ. 2008. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn-Schmiedeberg's archives of pharmacology, 378 :589-597 DOI Author Url Public Url
Penson PE, Ford WR, Broadley KJ. 2007. Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice? Pharmacology & therapeutics, 115 :37-55 DOI Author Url Public Url
Broadley KJ, Penson PE. 2006. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. European journal of pharmacology, 536 :279-286 DOI Author Url
Broadley KJ, Penson PE. 2004. The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia. Autonomic & autacoid pharmacology, 24 :87-93 DOI Author Url
Ritchie L, Qin S, Penson P, Henney N, Lip G. Vernakalant hydrochloride for the treatment of atrial fibrillation: An evaluation of its place in clinical practice Future Cardiology, DOI Author Url Public Url
Banach M, Penson P. Colchicine and Cardiovascular Outcomes: A Critical Appraisal of Recent Studies Current Atherosclerosis Reports, Public Url
Mahmoud A, Mullen R, Penson P, Morecroft C. The management of asthma in adult patients in the community pharmacy setting: literature review Research in Social and Administrative Pharmacy, Public Url
Editorial/letter to the editor
Banach M, Penson P. 2021. Drucebo Effect -The Challenge We Should All Definitely Face! Archives of Medical Science, DOI
Banach M, Penson P. 2020. Cellular senescence, telomeres and cardiovascular risk in familial hypercholesterolaemia European Journal of Preventative Cardiology, DOI Author Url
Banach M, Penson P. 2019. Statins and Lp(a): Don’t make perfect the enemy of excellent. European Heart Journal, DOI Author Url
Ritchie L, Penson P, Lane D. 2019. Warfarin therapy and improved anticoagulation control by patient self-management Thrombosis and Haemostasis, DOI Author Url
Banach M, Penson P. 2019. Genetic testing in familial hypercholesterolaemia: What does it add? European Journal of Preventative Cardiology, DOI Author Url
Penson P. 2017. Autonomic and Autacoid Pharmacology: Goodbye and thank you Autonomic and Autacoid Pharmacology, DOI Author Url
Penson PE. 2016. Autonomic & Autacoid Pharmacology 2016: The year in review. Auton Autacoid Pharmacol, 36 :27-27 DOI Author Url
Penson P. 2016. Autonomic & Autacoid Pharmacology: past, present and future Autonomic and Autacoid Pharmacology, DOI Author Url
Penson PE. 2009. Incense – A problematic method of drug-delivery Medical Hypotheses, 72 :482-482 DOI Author Url
Penson P. 2007. Peter Penson on one way to cut the NHS drugs budget The Health service journal, Author Url Publisher Url
Penson PE. 2006. Wasted journey [15] Pharmaceutical Journal, 276 :322
Penson PE. 2005. Academic rigour? [9] Pharmaceutical Journal, 275 :752
Penson P. 2004. Apply liberally [12] Pharmaceutical Journal, 273 :644
Penson P. 2004. Peddling products of dubious safety, quality and efficacy [12] Pharmaceutical Journal, 273 :21
Penson P. 2004. Not a new hazard [5] Pharmaceutical Journal, 272 :86
Penson P. 2003. An outsider's view of our profession [3] Pharmaceutical Journal, 271 :543
Chapters
Bartłomiejczyk M, Penson P, Banach M. 2020. Management of Statin Intolerance Davidson M, Toth PP, Maki K. Therapeutic Lipidology 2nd Ed SpringerNature DOI
Bartlomiejczyk M, Penson P, Banach M. 2020. Vitamin D and SAMS Thompson PD, Taylor B. Statin-Associated Muscle Symptoms Humana Press 978-3-030-33303-4 DOI
Penson P, Henney N. 2013. Homeostasis Gaskell E, Rostron C. Therapeutics and Human Physiology OUP Oxford 9780199655298 Author Url
Henney N, Penson P. 2013. Communication systems in the body - neural Gaskell E, Rostron C. Therapeutics and Human Physiology OUP Oxford 9780199655298 Author Url
Internet publication
Penson P, Banach M. 2020. Could we use statins to treat COVID-19? Publisher Url
Conference publication
Penson P, Martin SS, Henney N, Banach M. 2020. Comparison of LDL-C calculation by Friedewald and Martin/Hopkins methods in 12,243 adults from the United States of America European Society of Cardiology Congress 2020 DOI Author Url
Penson P, Toth P, Mikhailidis D, Ezhov M, Fras Z, Mitchenko O, Pella D, Sahebkar A, Rysz J, Reiner Z, Jozwiak J, Mazidi M, Banach M. 2019. P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel European Heart Journal, 40 DOI Author Url
Mahmoud A, Mullen R, Penson P, Morecroft C. 2019. Exploring the management and control of adult asthma patients: stakeholder perspectives in the North West of England International Journal of Pharmacy Practice, Health Services Research & Pharmacy Practice Conference 27 :49-49 DOI
Penson PE, Awad K, Lane D, Banach M, Lip GYH. 2018. P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis European Heart Journal, 39 DOI Author Url
Penson P, Long LD, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Catapano AL, Banach M. 2018. P5086Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study European Heart Journal, 39 DOI Author Url
Whiteoak A, Penson P. 2018. Novel electromechanical method for measuring toxic response in aquatic invertebrates Proc Physiol Soc, Experimental Models 40 :PC08-PC08 Author Url
Maguire E, Penson P, Davies H, McEntee J. 2017. What information about new medicines is needed by health care professionals? UKMi Practice Development Seminar :25-25 Author Url
Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Catapano AL, Banach M. 2017. P627Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study European Heart Journal, 38 DOI Author Url
Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Jones SR, Rysz J, Rizzo M, Howard G, Lip GYH, Banach M. 2017. 3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis European Heart Journal, 38 DOI Author Url
Penson P, Long DL, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2017. 3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study European Heart Journal, 38 DOI Author Url
M. Whiteoak A, E. Penson P. 2017. 220 Daphnia magna as a model for quantifying chaos in cardiac arrhythmia Heart, 103 :A143.2-A143 DOI Author Url
Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials European Heart Journal ( 2016 ) 37 ( ), 339, ESC Congress 2016 37 :39-39 DOI
Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, bluher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokine concentrations? a systematic review and meta-analysis of randomized controlled trials. European Heart Journal, ESC Congress, 2016 37 :546-547 DOI Author Url
Ursoniu S, Mikhailidis DP, Serban MC, Penson P, Toth PP, Ray KK, Kastelein JJP, Hernandez AV, Banach M. 2016. The effects of statins on cardiovascular outcomes by smoking status. a systematic review and meta-analysis of randomized controlled trials European Heart Journal, ESC Congress 2016 37 :991-992 DOI Author Url
Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban MC, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials EUROPEAN HEART JOURNAL, Congress of the European-Society-of-Cardiology (ESC) 37 :339-339 Author Url
Penson PE, Krska J, Stokes E, Mackridge AJ. 2013. Developing skills to deliver alcohol screening and brief intervention (SBI) in community pharmacy Addiction Science & Clinical Practice, 8 DOI Publisher Url
Krska J, Stokes E, Penson P, Mackridge A . 2013. Training needs of pharmacy staff providing an alcohol screening service The 9th Conference of INEBRIA Author Url
Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. ChemInform Abstract: Synthesis of Antagonists of Muscarinic (M3) Receptors. ChemInform, 42 :no-no DOI
Penson PE, Ford WR, Kidd EJ, Broadley KJ. 2008. Protective role of β2- and β3-adrenoceptors at reperfusion in isolated rat heart Journal of Molecular and Cellular Cardiology, 44 :719-719 DOI Author Url
Penson P, Ford W, Broadley K. 2007. Infarct-size reduction induced by ischaemic postconditioning is dependent on β2-adrenoceptor activation in the Langendorff perfused rat heart Proceedings of the British Pharmacological Society, British Pharmacological Society, Winter Meeting December 2007 :030p-030p Author Url Publisher Url
Penson P, Ford W, Kidd E, Broadley K. 2006. Preconditioning by the β-adrenoceptor agonist, isoprenaline, in the rat isolated atrium but not ventricle pA2 Online, British Pharmacological Society 75th Anniversary Meeting December 2006 :115P-115P Author Url Publisher Url
Other
Ritchie L, Penson P, Akpan A, Lip G, Lane D. 2020. Pharmacist implementation of a treatment pathway for atrial fibrillation in care home residents DOI
Thompson C, Penson P, Madden J. 2020. Research Protocol Registration: Systematic review to determine the chemical space of existing physiologically-based kinetic (PBK) models PROSPERO 2020 CRD42020171130, Publisher Url
Penson P, Mazidi M, Bartłomiejczyk M, Rakowski M, Jankowski P, Hernandez AV, Banach M. 2020. Research Protocol Registration: Risk factors associated with contracting COVID-19, and mortality PROSPERO 2020 CRD42020175666, Publisher Url
Penson P. 2019. Research Protocol Registration: Comparing the effects of statin monotherapy, and statins in combination, with other lipid-lowering agents on plasma lipoprotein(a) PROSPERO 2019 CRD42019145229, Publisher Url
Mozidi M, Penson P, Banach M. 2019. Research Protocol Registration: Risk factors for statin intolerance PROSPERO 2019 CRD42019145189, Publisher Url
Penson P, Banach M. 2017. Research Protocol Registration: A systematic review and meta-analysis to compare reported rates of statin-associated muscle symptoms, under blinded and open-label conditions PROSPERO, :PROSPERO 2017-CRD42017082700 Author Url Publisher Url
Banach M, Awad K, Penson P, Lane D, Lip GYH. 2016. Research Protocol Registration: The prognostic accuracy of stroke risk prediction scores for patients with atrial fibrillation: a systematic review and meta-analysis :PROSPERO 2016-CRD42016052271 Author Url Publisher Url
Banach M, Awad K, Penson P, Lane D, Lip GYH. 2016. Research Protocol Registration: The prognostic accuracy of risk prediction scores for bleeding: a systematic review and meta-analysis :PROSPERO 2016-CRD42016052259
Penson P, Serban MC, Banach M. 2016. Research Protocol Registration: Association of cholesterol efflux activity with major adverse cardiovascular events :PROSPERO 2016-CRD42016039035 Author Url Publisher Url
Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Banach M. 2016. Research Protocol Registration: Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis :PROSPERO 2016-PROSPERO 2016 Author Url Publisher Url
Serban MC, Penson P, Sahebkar A, Ursoniu S, Gurban C, Banach M. 2016. Research Protocol Registration: Impact of tamoxifen on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of prospective studies :PROSPERO 2016-CRD42016036890 Author Url Publisher Url
Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow W, Muntner P, Lip G, Wong N, Rysz J. 2016. Research Protocol Registration: Effects of Pentoxifylline on blood pressure and inflammatory markers: a systematic review and meta-analysis of randomized controlled trials :PROSPERO 2016-CRD42016035988 Author Url Publisher Url
Penson P, Serban MC, Andrica F, Banach M. 2015. Research Protocol Registration: Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review and meta-analysis :PROSPERO 2015-CRD42015032335 Author Url Publisher Url
Dataset
Sayre R, Grulke C, Tan Y-M, Madden J, Thompson C, Webb S, Penson P. 2019. Existing physiologically-based kinetic (PBK) models, identified via PubMed searches (with associated EndNote library) DOI
Book
Gaskell EE, Evans A, Henney N, Penson P, Elliott PNC, Burrell H, Airley R, Ford W, Lane E, Allison GL. 2013. Therapeutics and Human Physiology Gaskell EE, Rostron C. OUP Oxford. Oxford, UK 9780199655298 Author Url Publisher Url
Report
Stokes E, Penson P, Mackridge A, Krska J. 2012. Evaluation of the training needs of pharmacy staff delivering an alcohol Identification and Brief Advice (IBA) service :1-1
Thesis/Dissertation
Penson P. 2009. β-adrenoceptor subtypes involved in myocardial preconditioning and postconditioning http://orca.cf.ac.uk/54502/ Broadley KJ, Ford WR, Kidd EJ. Cardiff University Publisher Url
Highlighted activities
External PGR examinations performed:
Liverpool John Moores University, MPhil, An investigation into the implications of switching to extended intermittent infusions rather than standard practice of antibiotic administration in critically ill patients with sepsis. 2019
University of Birmingham, PhD, Anticoagulation control in patients with AF. 2019
Other Professional Activity:
External Examiner, Faculty of Health and Applied Sciences, UWE Bristol (2018-2022).
Professional activities
External committees:
Working Group on Atherosclerosis and Vascular Biology, European Society of Cardiology, Member. 2021
Medical Scientific and Research Committee, Heart UK, Committee Member, https://www.heartuk.org.uk/. 2020
International Lipid Expert Panel, (ILEP), http://ilep.eu/. 2018
Abstract Reviewer, British Pharmacological Society (Pharmacology 2017). 2017
Lipid and Blood Pressure Meta-analysis Collaboration Group, (LBPMCG), http://lbpmcgroup.umed.pl/. 2015
Editorial boards:
British Journal of Clinical Pharmacology, Executive Editor. 2020
BMC Pharmacology and Toxicology, Associate Editor. 2017
The Young Darwinian, Member of Editorial Board. 2017
Archives of Medical Science - Civilization Diseases, Section Editor. 2016
Autonomic and Autacoid Pharmacology, Editor-In-Chief. 2016
Conference organisation:
Pharmacology 2019 (British Pharmacological Society), Abstract Reviewer. 2019
Pharmacology 2018 (British Pharmacological Society), Abstract Reviewer. 2018
Pharmacology 2017 (British Pharmacological Society), Abstract Reviewer. 2017
Autonomic, Respiratory and Cardiovascular Pharmacology: A Festschrift Symposium in Honour of the 65th Birthday of Professor Ken Broadley., Organiser. 2008
Other invited event:
Heart UK 33rd Annual Medical & Scientific Conference, Warwick UK, Invited Lecture: Evidence-based use of lipid-lowering nutraceuticals. 2019
Heart UK 15th Northwest Diabetes, Endocrinology and Cardiovascular Update, Manchester, United Kingdom, Invited Lecture: Nutraceuticals in Clinical Practice. 2018
Heart UK 11th North West Lipid and Atherosclerosis Forum, Manchester UK, Keynote Lecture: Lipid-Lowering Nutraceuticals in Clinical Practice. 2018
Invited Talk: Management of Statin Intolerance, International Lipid Expert Panel (Munich, Germany), Invited Talk. 2018
5th Meeting of the Hyperlipidemia Academy, Madrid, Spain, Invited Lecture. 2017
2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Vienna, Session Chair: Heart Failure management in the elderly. 2017
2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Vienna, Invited Lecture: Lipids as Predictors of Clinical Outcomes in Older Adults. 2017
The heart of the matter: Insights into cardiovascular risk reduction from the Lipid and Blood Pressure Meta-Analysis Collaboration Group, University of Salford, Invited Seminar. 2017
The 1st Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Bratislava, Slovakia, Session Chair: Nutraceuticals. 2016
Seminar: Careers in Academia, Cardiff University, Careers in Academia. 2014
Membership of professional bodies:
Member, Cochrane. 2019
Member, British Cardiovascular Society, https://www.bcs.com/pages/default.asp. 2016
Member, European Society of Cardiology, http://www.escardio.org/. 2016
Ordinary Member, European Society of Cardiology. 2015
Member, British Society for Heart Failure, http://www.bsh.org.uk/. 2015
Member of the British Society for Cardiovascular Research, British Society for Cardiovascular Research. 2009
British Pharmacological Society (Full Member), British Pharmacological Society. 2005
Member of the Royal Pharmaceutical Society, Royal Pharmaceutical Society. 2005
External PGR examinations performed:
Liverpool John Moores University, MPhil, An investigation into the implications of switching to extended intermittent infusions rather than standard practice of antibiotic administration in critically ill patients with sepsis. 2019
University of Birmingham, PhD, Anticoagulation control in patients with AF. 2019
Coventry University, MPhil, TBC. 2010
Research Grants Awarded:
European Partnership for Alternative Approaches to Animal Testing, Tools to Support Application of Physiologically-Based Kinetic Modelling in Safety Assessment, Dr Judith C. Madden (LJMU), Dr Steven Webb (LJMO), Grant value (£): 82,000, Duration of research project: 3 Years. 2019
Isra University, Jordan, Phd Studentship, Adam Mackridge, Rachel Mullen, Grant value (£): 23,400, Duration of research project: 3 Years. 2017
Sefton Primary Care Trust, Design, implementation and evaluation of an educational intervention to assist pharmacy staff in delivering an Alcohol IBA scheme, Mackridge,A; Krska,J, Grant value (£): 13000, Duration of research project: 1/1. 2011
Award:
Top 1% Reviewer in the field of Clinical Medicine, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=8. 2018
Top 1% Reviewer in the field of Multidisciplinary Research, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=22. 2018
Top 1% Reviewer in the field of Pharmacology and Toxicology, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=5. 2018
Publons: Top 1% of Peer reviewers in the field of Medicine (64th place worldwide), Publons Peer Review Awards 2017, http://bit.ly/Publons17. 2017
Publons: Sentinels of Science 2016: Top 10% Reviewer in the field of Medicine, Publons, http://bit.ly/Publons16. 2016
Nominated for Amazing Teaching Award (2016), Liverpool Students' Union. 2016
Nominated for Amazing Teaching Award (2015), Liverpool Students' Union. 2015
Nominated for Amazing Teaching Award (2013), Liverpool Students' Union. 2013
Prize Awarded for Outstanding Poster, International Network on Brief Interventions for Alcohol and Other Drugs at the 9th International INEBRIA conference, Barcelona, http://bit.ly/Inebria9. 2012
The GlaxoSmithKline Award for the Best Pharmacology Student, The Science, Engineering & Technology Student of the Year Awards and the British Pharmacological Society. 2004
Teaching qualification:
PGCert Learning and Teaching in Higher Education. 2011
Fellowships:
Higher Education Academy, Higher Education Academy. 2010
Other Professional Activity:
External Examiner, Faculty of Health and Applied Sciences, UWE Bristol (2018-2022).